Search Results
Results found for "Martin Audet"
- Martin Audet | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Martin Audet About Dr. Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging Martin Audet on the web LinkedIn Twitter Sherbrooke University Google Scholar Dr.
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
Jean Martin Beaulieu About Dr. Jean Martin Beaulieu Dr. Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research About Martin Marro Dr. Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell , Jean-Pierre Changeux , and Martin Karplus .
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge
- Dr. Timo De Groof | Dr. GPCR Ecosystem
Martine Smit . During his Ph.D., Timo, together with Dr.
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr.
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
in Molecular Pharmacology at Monash University, then trained in single-cell biology as an NHMRC CJ Martin
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
that support scale ✅ Create investor-ready operating structures Our Partners Benefit From: Strategy Audits
- YC-VC Insights | Dr. GPCR Ecosystem
Audit and compare CRO options based on speed, quality, and fit Clarify deliverables and oversight to
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
contains the phrase "machine learning" whether they fully believe in it or not, this panel is an honest audit
- Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
the most drugged protein family in medicine, but until recently their role in cancer was treated as marginal
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
look at what it means to modulate opioid pharmacology downstream of the receptor — and why the safety margins













